Ambiq Micro, INC

Market Movers (8-K)

See all →
NYSE
Ambiq Micro announced record quarterly net sales up 90% year-over-year for Q2 2026, driven by strong demand for its ultra-low-power semiconductor solutions for edge AI.
Better than expected
Capital raise
NYSE
Ambiq Micro celebrates its first year as a public company, highlighting IPO success, capital raises, technological advancements in edge AI, and a positive outlook for future growth.
Capital raise
NYSE
Ambiq Micro, Inc. announced the results of its 2026 Annual Meeting of Stockholders, including the election of two Class I directors and the ratification of KPMG LLP as its independent auditor.
NYSE
Ambiq Micro announced first quarter 2026 financial results, exceeding guidance with a 59.3% year-over-year increase in net sales driven by strong demand for its ultra-low-power edge AI solutions.
Better than expected
NYSE
Ambiq Micro announced robust fourth quarter and full year 2025 financial results, driven by accelerated customer demand and strategic advancements in edge AI solutions.
Better than expected
Capital raise
NYSE
Ambiq Micro, Inc. disclosed preliminary unaudited financial results for the year ended December 31, 2025, projecting net sales between $71.77 million and $72.47 million.

Quarterly Earnings (10-Q)

NYSE
Ambiq Micro reports a substantial 89.7% increase in net sales for the quarter ended June 30, 2026, driven by new product launches and customer adoption, while continuing to invest heavily in R&D.
Better than expected
Capital raise
NYSE
Ambiq Micro's Q1 2026 results show a 59.3% surge in net sales driven by new product launches and increased customer demand, though net loss widened.
Capital raise
Worse than expected
NYSE
Ambiq Micro reports improved gross margins and reduced net loss for the nine months ended September 30, 2025, driven by a strategic shift away from Mainland China following its July 2025 IPO.
Capital raise
NYSE
Ambiq Micro reports improved gross margins and reduced net losses in Q2 2025, driven by a strategic pivot away from Mainland China and a successful post-period IPO.
Capital raise
Better than expected

Annual Reports (10-K)

NYSE
Ambiq Micro's 2025 annual report reveals a strategic shift to higher-margin edge AI markets, resulting in improved gross margins despite a slight dip in net sales and continued net losses.
Capital raise
Worse than expected

Insider Trading (Form 4)

See all →
NYSE
Scott Mclean Hanson, Chief Technology Officer and a Director of Ambiq Micro, Inc., sold 7,000 shares of common stock on August 14, 2026.
NYSE
Director Wen Hsuan Hsieh was granted 4,957 restricted stock units as part of the company's 2025 Equity Incentive Plan.
NYSE
Ambiq Micro, Inc. reports a Form 4 filing detailing a restricted stock unit grant to Director Timothy Chen.
NYSE
Ambiq Micro, Inc. reports that Director Bernard Bennett received 4,957 Restricted Stock Units (RSUs) on June 8, 2026.
NYSE
Joseph A. Tautges, a Director at Ambiq Micro, Inc., was granted 4,957 Restricted Stock Units (RSUs) on June 8, 2026.
NYSE
Ambiq Micro, Inc. reports a grant of 4,957 restricted stock units to Director Ker Zhang, vesting over three years.

New Public Companies (S-1)

NYSE
Ambiq Micro, Inc. filed an S-1MEF to increase the number of common stock shares offered in its public offering by 551,540, including underwriter options.
Better than expected
Capital raise
NYSE
Ambiq Micro, a leader in ultra-low power semiconductor solutions for edge AI, filed an S-1 registration statement for a public offering of 2.2 million shares, aiming to fund growth despite recent net losses.
Capital raise
NYSE
Ambiq Micro, Inc. has filed an S-1MEF to increase its common stock offering by 690,000 shares, including an underwriters' option, signaling robust demand for its initial public offering.
Capital raise
Better than expected
NYSE
Ambiq Micro, a pioneer in ultra-low power semiconductor solutions for edge AI, is seeking to raise approximately $68.8 million through its initial public offering to accelerate product development and expand into new high-growth markets.
Better than expected
Capital raise
NYSE
Ambiq Micro, a pioneer in ultra-low power semiconductor solutions for edge AI, has filed for an initial public offering to fund its growth strategy, despite a history of net losses and significant customer concentration.
Capital raise

Schedule 13G - Passive Investments

NYSE
Investment firm Kleiner Perkins and its affiliated entities have disclosed an aggregate beneficial ownership of 8.2% of Ambiq Micro, Inc.'s common stock.